Journal of Clinical Pathology 2007;60:1076-1085
MY APPROACH
Nodal aggressive B-cell lymphomas: a diagnostic approach
Division of Hematopathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Correspondence to:
Dr Steven H Swerdlow, Division of Hematopathology, University of Pittsburgh School of Medicine, UPMC-Presbyterian, Room C606, 200 Lothrop Street, Pittsburgh, PA 15213, USA; swerdlowsh{at}upmc.edu
The diffuse aggressive B-cell lymphomas, as recognised in the 2001 WHO classification, represent a clinically and biologically heterogeneous group of neoplasms that require very different therapeutic approaches and have very different outcomes. They should be diagnosed using a multiparameter approach that emphasises morphological and immunophenotypic studies, and in at least some cases, relies on cytogenetic and/or genotypic studies. Incorporation of clinical data may be important as well. There is also current interest in going beyond the basic diagnosis and providing pathological prognostic information when possible. Whereas the diagnosis of some cases will be relatively easy, the differential diagnosis in others is very difficult, with some cases in a grey zone between two different well defined categories.
Keywords: aggressive B-cell lymphoma; B-cell lymphoma; Burkitt lymphoma; diffuse large cell lymphoma; high grade B-cell lymphoma
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
